Royal Biologics Launches Amnio-Maxx™, a Stem Cell Product Derived From Human Amniotic Placental Tissue – PR Newswire (press release)
PR Newswire (press release) |
Royal Biologics Launches Amnio-Maxx™, a Stem Cell Product Derived From Human Amniotic Placental Tissue
PR Newswire (press release) 6, 2018 /PRNewswire/ — Royal Biologics, an ortho-biologics company specializing in the research and advancement of regenerative cellular therapy, has announced the launch of their new amniotic stem cell product. Amnio-Maxx ™ is a stem cell product … |
